Michael Millenson

8.9k citations
65 papers · 4.6k · 2 hit papers · h-index 22

Impact in

    • Lymphoma Diagnosis and Treatment
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Viral-associated cancers and disorders

Papers in

    • Lymphoma Diagnosis and Treatment 34
    • Viral-associated cancers and disorders 12
    • Cancer Treatment and Pharmacology 6
    • Colorectal Cancer Treatments and Studies 4

Michael Millenson

64 papers receiving 4.5k citations

Michael Millenson's Hit Papers

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma 2014 · 2.8k citations
2.8k0+4+8Years since publication50010001.5k2.0k2.5k

Peers

Michael Millenson
Comparison fields: 5 of 98
  • Pathology and Forensic Medicine 1.8k
  • Oncology 2.6k
  • Genetics 627
  • Immunology 1.3k
  • Neurology 516
Replace Martin Gutierrez with:
Martin Gutierrez United States
Dok Hyun Yoon South Korea
Ahmad Halwani United States
John Sweetenham United States
Kieron Dunleavy United States
Paul A. Hamlin United States
R. Gregory Bociek United States
Paul Hoskins Canada
Mark Roschewski United States
Simon Rule United Kingdom
Michael Millenson relative to Martin Gutierrez United States Martin Gutierrez's profile →
Citations per field
00.5×1.6×
Martin Gutierrez · 1×
Citations per year

Countries citing papers authored by Michael Millenson

Since Specialization
Citations

This map shows the geographic impact of Michael Millenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Millenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Millenson more than expected).

Fields of papers citing papers by Michael Millenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Millenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Millenson. The network helps show where Michael Millenson may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Millenson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Millenson Line = papers co-authored together Michael Millenson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Hit paper breakdown →
20142756
2
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Hit paper breakdown →
2013638
3 2012175
4 201167
5 201267
6 200865
7 201754
8 201352
9 200548
10 201348
11 200843
12 201436
13 200336
14 200235
15 200633
16 201332
17 200730
18 201128
19 201427
20
NCCN Practice Guidelines for Acute Myelogenous Leukemia.
200027

About Michael Millenson

Michael Millenson is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Genetics and Neurology, having authored 65 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (34 papers), Viral-associated cancers and disorders (12 papers), Lung Cancer Treatments and Mutations (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), CNS Lymphoma Diagnosis and Treatment (8 papers), Cancer Treatment and Pharmacology (6 papers), Immune Cell Function and Interaction (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.8k citations), Oncology (2.6k citations), Genetics (627 citations), Immunology (1.3k citations) and Neurology (516 citations). Michael Millenson has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Scott J. Rodig, Philippe Armand, Ahmad Halwani, Stephen J. Schuster, Deepika Cattry, Alexander M. Lesokhin, Stephen M. Ansell, Emma C. Scott, Bjoern Chapuy and Margaret A. Shipp. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Journal of Thoracic Oncology and Journal of the National Comprehensive Cancer Network.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact